(Q38315714)

2 September 2017

Selenoprotein P and selenoprotein M block Zn2+ -mediated Aβ42 aggregation and toxicity (English)

1 reference

2 September 2017

Xiubo Du

1

1 reference

2 September 2017

Haiping Li

2

1 reference

2 September 2017

Zhi Wang

3

1 reference

2 September 2017

Shi Qiu

4

1 reference

2 September 2017

Qiong Liu

5

1 reference

2 September 2017

Jiazuan Ni

6

1 reference

2 September 2017

1 June 2013

1 reference

2 September 2017

1 reference

2 September 2017

5

1 reference

2 September 2017

7

1 reference

2 September 2017

861-870

1 reference

A century of Alzheimer's disease

2 September 2017

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

Alzheimer's disease: from pathology to therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

Intracellular amyloid-beta in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

Abeta42 is essential for parenchymal and vascular amyloid deposition in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

Structural basis for increased toxicity of pathological aβ42:aβ40 ratios in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

The metallobiology of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

Iron accumulation in Alzheimer disease is a source of redox-generated free radicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

Copper, iron and zinc in Alzheimer's disease senile plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-beta peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

Bifunctional compounds for controlling metal-mediated aggregation of the aβ42 peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

Copper and zinc binding to amyloid-beta: coordination, dynamics, aggregation, reactivity and metal-ion transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

The chemistry of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

Oxygen toxicity, oxygen radicals, transition metals and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

Design, selection, and characterization of thioflavin-based intercalation compounds with metal chelating properties for application in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

The native copper- and zinc-binding protein metallothionein blocks copper-mediated Abeta aggregation and toxicity in rat cortical neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

The molecular mechanism for human metallothionein-3 to protect against the neuronal cytotoxicity of Aβ(1-42) with Cu ions

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

Zinc release of Zn₇-metallothionein-3 induces fibrillar type amyloid-β aggregates

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

The selenoproteome exhibits widely varying, tissue-specific dependence on selenoprotein P for selenium supply

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

Selenoprotein P: an extracellular protein with unique physical characteristics and a role in selenium homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

Involvement of selenoprotein P in protection of human astrocytes from oxidative damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

Gene regulation and DNA damage in the ageing human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

The human selenoproteome: recent insights into functions and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

Mammalian selenoprotein in which selenocysteine (Sec) incorporation is supported by a new form of Sec insertion sequence element

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

The neuroprotective functions of selenoprotein M and its role in cytosolic calcium regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

Different Forms of Selenoprotein M Differentially Affect Aβ Aggregation and ROS Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

SelT, SelW, SelH, and Rdx12: genomics and molecular insights into the functions of selenoproteins of a novel thioredoxin-like family

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

Dual nanomolar and picomolar Zn(II) binding properties of metallothionein

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

Zinc finger antiviral protein inhibits murine gammaherpesvirus 68 M2 expression and regulates viral latency in cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

Metals and the liver in Alzheimer's disease. An investigation of hepatic zinc, copper, cadmium, and metallothionein

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

Cadmium in blood in Alzheimer's disease and non-demented subjects: results from a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

Transition metal abnormalities in progressive dementias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

Solution structure and dynamics of human metallothionein-3 (MT-3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

Binding of zinc(II) and copper(II) to the full-length Alzheimer's amyloid-beta peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

Inhibitory effect of curcumin on the Al(III)-induced Aβ₄₂ aggregation and neurotoxicity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

Modulation of amyloid-β 1-42 structure and toxicity by proline-rich whey peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

Neuroprotection by hypothalamic peptide proline-rich peptide-1 in Abeta25-35 model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

Neuroprotective action of proline-rich polypeptide-1 in β-amyloid induced neurodegeneration in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

Zn(II)- and Cu(II)-induced non-fibrillar aggregates of amyloid-beta (1-42) peptide are transformed to amyloid fibrils, both spontaneously and under the influence of metal chelators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

Medicinal inorganic chemistry approaches to passivation and removal of aberrant metal ions in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

Therapeutics for Alzheimer's disease based on the metal hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

Alzheimer's disease, metal ions and metal homeostatic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

Metals ions and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

Causes of oxidative stress in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

NADPH-oxidase-derived reactive oxygen species mediate the cerebrovascular dysfunction induced by the amyloid beta peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

RAGE and amyloid beta interactions: atomic force microscopy and molecular modeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

NAD(P)H oxidase-mediated reactive oxygen species production alters astrocyte membrane molecular order via phospholipase A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

Abeta-mediated ROS production by Cu ions: structural insights, mechanisms and relevance to Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

Inhibiting effect of αs1-casein on Aβ1–40 fibrillogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20282H

21 January 2018

Identifiers

DOI

10.1039/C3MT20282H

1 reference

2 September 2017

1 reference